5 min listen
Walmsley's GSK gamble
FromFT News in Focus
ratings:
Length:
9 minutes
Released:
Dec 24, 2018
Format:
Podcast episode
Description
GlaxoSmithKline is combining its consumer health business with that of US rival Pfizer, paving the way for a separation of its core consumer and pharmaceuticals businesses within three years. Chief executive Emma Walmsley is betting the cash generated by the enlarged consumer unit will fund further investment in the pharmaceutical business ahead of the demerger. Matthew Vincent is joined by Sarah Neville and Arash Massoudi to discuss the merits of the deal and its implications for the health and pharmaceuticals markets.Contributors: Naomi Rovnick, FT Live reporter, Matthew Vincent, Lombard columnist, Sarah Neville, global pharmaceuticals editor and Arash Massoudi, corporate finance and deals editor. Producer: Sam Westran For information regarding your data privacy, visit acast.com/privacy
Released:
Dec 24, 2018
Format:
Podcast episode
Titles in the series (100)
Eyewitness report: Earthquake relief efforts in Haiti by FT News in Focus